Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne D Conzen

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Molecular Endocrinology (Baltimore, Md.)|April 18, 2008
Minireview: nuclear receptors and breast cancerSuzanne D Conzen
Bioinformatics (Oxford, England)|August 17, 2004
A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray dataMin Zou, Suzanne D Conzen
Cancer Biomarkers : Section a of Disease Markers|August 6, 2013
The role of adrenergic signaling in breast cancer biologyElias I Obeid, Suzanne D Conzen
Brain, Behavior, and Immunity|November 21, 2012
The influence of glucocorticoid signaling on tumor progressionPaul A Volden, Suzanne D Conzen
The Journal of Steroid Biochemistry and Molecular Biology|May 11, 2024
Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtypeAbigail B Clark, Suzanne D Conzen
Cancer Research|August 27, 2011
Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancerDeng Pan, Masha Kocherginsky, Suzanne D Conzen
Science Translational Medicine|September 18, 2015
Targeting the glucocorticoid receptor in breast and prostate cancersJacob Kach, Suzanne D Conzen, Russell Z Szmulewitz
European Journal of Cancer (Oxford, England : 1990)|October 26, 2005
Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancerSunati Sahoo, Deanna R Brickley, Masha Kocherginsky, et al.
Endocrinology|February 2, 2008
Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathwayTravis Pew, Min Zou, Deanna R Brickley, et al.
The Journal of Biological Chemistry|December 14, 2004
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survivalWei Wu, Travis Pew, Min Zou, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Molecular Endocrinology (Baltimore, Md.)|April 18, 2008
Minireview: nuclear receptors and breast cancerSuzanne D Conzen
Bioinformatics (Oxford, England)|August 17, 2004
A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray dataMin Zou, Suzanne D Conzen
Cancer Biomarkers : Section a of Disease Markers|August 6, 2013
The role of adrenergic signaling in breast cancer biologyElias I Obeid, Suzanne D Conzen
Brain, Behavior, and Immunity|November 21, 2012
The influence of glucocorticoid signaling on tumor progressionPaul A Volden, Suzanne D Conzen
The Journal of Steroid Biochemistry and Molecular Biology|May 11, 2024
Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtypeAbigail B Clark, Suzanne D Conzen
Cancer Research|August 27, 2011
Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancerDeng Pan, Masha Kocherginsky, Suzanne D Conzen
Science Translational Medicine|September 18, 2015
Targeting the glucocorticoid receptor in breast and prostate cancersJacob Kach, Suzanne D Conzen, Russell Z Szmulewitz
European Journal of Cancer (Oxford, England : 1990)|October 26, 2005
Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancerSunati Sahoo, Deanna R Brickley, Masha Kocherginsky, et al.
Endocrinology|February 2, 2008
Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathwayTravis Pew, Min Zou, Deanna R Brickley, et al.
The Journal of Biological Chemistry|December 14, 2004
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survivalWei Wu, Travis Pew, Min Zou, et al.
Pageof 8